NCT06506903 - Avalus Ultra Post-Approval Study (PAS) | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions

Aortic Valve Disease

Interventions

DEVICE

Medtronic Avalus Ultra

Surgical aortic valve replacement with the Medtronic Avalus Ultra bioprosthesis for management of aortic stenosis and regurgitation.

Trial Locations (13)

13203

RECRUITING

St. Joseph's Hospital Health Center, Syracuse

30060

RECRUITING

WellStar Kennestone Hospital, Marietta

30342

RECRUITING

Emory Saint Joseph's, Atlanta

32610

RECRUITING

University of Florida Shands, Gainesville

43606

RECRUITING

ProMedica Toledo Hospital, Toledo

44106

RECRUITING

UH Cleveland Medical Center, Cleveland

48109

RECRUITING

University of Michigan Health System - University Hospital, Ann Arbor

55902

RECRUITING

Mayo Clinic, Rochester

60611

RECRUITING

Northwestern Memorial Hospital, Chicago

77030

RECRUITING

Houston Methodist Hospital, Houston

78756

RECRUITING

Heart Hospital of Austin, Austin

98122

RECRUITING

Swedish Medical Center Cherry Hill, Seattle

06106

RECRUITING

Hartford Hospital, Hartford

All Listed Sponsors

lead

Medtronic Cardiac Surgery

INDUSTRY